These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial. Gibel A; Ritsner MS Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244 [TBL] [Abstract][Full Text] [Related]
43. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency. Chen HK; Chen CK; Tzeng NS Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910 [No Abstract] [Full Text] [Related]
44. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
46. Ziprasidone: from pharmacology to the clinical practice. One year of experience. Baca E; Azanza JR; Giner J; Saiz-Ruiz J; Vallejo J; Diez T; Madrigal M Actas Esp Psiquiatr; 2005; 33(5):311-24. PubMed ID: 16155814 [TBL] [Abstract][Full Text] [Related]
47. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
48. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
49. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Hermida RC; Ayala DE; Khder Y; Calvo C Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247 [TBL] [Abstract][Full Text] [Related]
50. Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications. Jerrell JM; McIntyre RS Hum Psychopharmacol; 2007 Aug; 22(6):361-4. PubMed ID: 17562519 [TBL] [Abstract][Full Text] [Related]
51. The highest intentional ziprasidone overdose was not fatal. Prieto T; Benabarre A; Bernardo M Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953 [No Abstract] [Full Text] [Related]
52. A case series of ziprasidone overdoses. Bryant SM; Zilberstein J; Cumpston KL; Magdziarz DD; Costerisan DD Vet Hum Toxicol; 2003 Mar; 45(2):81-2. PubMed ID: 12678292 [TBL] [Abstract][Full Text] [Related]
53. Serotonin syndrome caused by ziprasidone alone. Lin PY; Hong CJ; Tsai SJ Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736 [No Abstract] [Full Text] [Related]
54. Ziprasidone-associated galactorrhea in a female teenager. Jordan MP J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):4-5. PubMed ID: 12500070 [No Abstract] [Full Text] [Related]
55. Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review. Gómez-Criado MS; Bernardo M; Florez Td; Gutiérrez JR; Gandía R; Ayani I Pharmacotherapy; 2005 Nov; 25(11):1660-5. PubMed ID: 16232029 [TBL] [Abstract][Full Text] [Related]